Gut liver brain axis in diseases: the implications for therapeutic interventions

M Yan, S Man, B Sun, L Ma, L Guo, L Huang… - Signal Transduction and …, 2023 - nature.com
Gut-liver-brain axis is a three-way highway of information interaction system among the
gastrointestinal tract, liver, and nervous systems. In the past few decades, breakthrough …

[HTML][HTML] A new perspective on NAFLD: Focusing on the crosstalk between peroxisome proliferator-activated receptor alpha (PPARα) and farnesoid X receptor (FXR)

S Zhou, H You, S Qiu, D Yu, Y Bai, J He, H Cao… - Biomedicine & …, 2022 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) is primarily caused by abnormal lipid metabolism
and the accumulation of triglycerides in the liver. NAFLD is also associated with hepatic …

Bile formation and secretion: an update

JL Boyer, CJ Soroka - Journal of hepatology, 2021 - Elsevier
Bile formation is a fundamental physiological process that is vital to the survival of all
vertebrates. However, little was known about the mechanisms of this secretion until after …

Resveratrol intervention attenuates chylomicron secretion via repressing intestinal FXR-induced expression of scavenger receptor SR-B1

J Pang, F Raka, AA Heirali, W Shao, D Liu, J Gu… - Nature …, 2023 - nature.com
Two common features of dietary polyphenols have hampered our mechanistic
understanding of their beneficial effects for decades: targeting multiple organs and …

therapeutic aspects of bile acid signalling in the gut‐liver axis

B Simbrunner, M Trauner… - Alimentary Pharmacology …, 2021 - Wiley Online Library
Background Bile acids are important endocrine modulators of intestinal and hepatic
signalling cascades orchestrating critical pathophysiological processes in various liver …

Bile acid metabolism and signaling: emerging pharmacological targets of dietary polyphenols

KM Tveter, E Mezhibovsky, Y Wu… - Pharmacology & …, 2023 - Elsevier
Beyond their role as emulsifiers of lipophilic compounds, bile acids (BAs) are signaling
endocrine molecules that show differential affinity and specificity for a variety of canonical …

Hepatic solute carrier transporters and drug therapy: Regulation of expression and impact of genetic variation

AT Nies, E Schaeffeler, M Schwab - Pharmacology & Therapeutics, 2022 - Elsevier
Organic cation transporters (OCT), organic anion transporting polypeptides (OATP) and
organic anion transporters (OAT) from the solute carrier (SLC) family play an essential role …

Discovery of the first-in-class intestinal restricted FXR and FABP1 dual modulator ZLY28 for the treatment of nonalcoholic fatty liver disease

Q Ren, Y Chen, Z Zhou, Z Cai, S Jiao… - Journal of Medicinal …, 2023 - ACS Publications
The prevalence of nonalcoholic steatohepatitis (NASH) is increasing rapidly worldwide, and
NASH has become a serious problem for human health. Recently, the selective activation of …

[PDF][PDF] Targeting the four pillars of enterohepatic bile salt cycling; lessons from genetics and pharmacology

RF Kunst, HJ Verkade, RPJ Oude Elferink… - …, 2021 - Wiley Online Library
Bile salts play a pivotal role in lipid homeostasis, are sensed by specialized receptors, and
have been implicated in various disorders affecting the gut or liver. They may play a role …

Discovery of LH10, a novel fexaramine-based FXR agonist for the treatment of liver disease

W Huang, Z Cao, W Wang, Z Yang, S Jiao, Y Chen… - Bioorganic …, 2024 - Elsevier
Farnesoid X receptor (FXR) was considered as a promising drug target in the treatment of
cholestasis, drug-induced liver injury, and non-alcoholic steatohepatitis (NASH). However …